Month: March 2019

To help women successfully take control of their finances, she encourages investing with confidence, rather than stashing cash in a low-yield savings account. While zero-risk cash investments are entirely appropriate for short-term needs, such as an emergency fund, savers will lose money in the long run by trailing the rate of inflation. “We put and
0 Comments
Wealthfront’s strategy is to automate an investment process that was once largely done by humans, from account set up to fund selection and account maintenance. All of this hinges on its customers trusting computers, hence, the firm’s target audience are tech-savvy millennial investors. So far, Wealthfront has signed up 270,000 accounts, with roughly $13 billion
0 Comments
CNBC’s Jim Cramer reminded investors not to step into a battleground stock, a situation where passionate bears are in a standoff with passionate bulls and there’s no where to go. “When you get a situation like Monster where a stock keeps getting mauled by the bears, but a couple of heroic analysts remain bullish, that’s
0 Comments
Apple’s AirPower charger has been cancelled, Apple confirmed on Friday. “After much effort, we’ve concluded AirPower will not achieve our high standards and we have cancelled the project. We apologize to those customers who were looking forward to this launch. We continue to believe that the future is wireless and are committed to push the
0 Comments
Shannon Stapleton | Reuters Signage for Lyft is seen displayed at the NASDAQ MarketSite in Times Square in celebration of its initial public offering (IPO) on the NASDAQ Stock Market in New York, U.S., March 29, 2019. Check out the companies making headlines midday Friday: Celgene — Shares of Celgene rose 7.8 percent after proxy
0 Comments
Activist investor Starboard Value has ended its fight against Bristol-Myers Squibb’s buyout of biotechnology company Celgene after two prominent proxy advisors announced their support for the deal earlier on Friday. The withdrawal comes hours after both Institutional Shareholder Services and Glass Lewis recommended Bristol-Myers shareholders vote in favor of its bid. “Despite the substantial swell
0 Comments